PRAMINE (imipramine hydrochloride) by Novartis is clinical pharmacology the mechanism of action of imipramine hydrochloride is not definitely known. Approved for depression, depression. First approved in 1978.
Drug data last refreshed 18h ago
CLINICAL PHARMACOLOGY The mechanism of action of imipramine hydrochloride is not definitely known. However, it does not act primarily by stimulation of the central nervous system. The clinical effect is hypothesized as being due to potentiation of adrenergic synapses by blocking uptake of…
A Phase 2 Study of On-demand Therapy With Clomipramine and Sildenafil Combination in Premature Ejaculation
Drug-Drug Interaction of Clomipramine HCl and Sildenafil Citrate in Healthy Males
A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine
Study of VX-770 on Desipramine
Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male Subjects
Worked on PRAMINE at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.